11-(3-oxocycloprop-1-enyl)undecanoic acid

ID: ALA5275210

Chembl Id: CHEMBL5275210

Max Phase: Preclinical

Molecular Formula: C14H22O3

Molecular Weight: 238.33

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CCCCCCCCCCc1cc1=O

Standard InChI:  InChI=1S/C14H22O3/c15-13-11-12(13)9-7-5-3-1-2-4-6-8-10-14(16)17/h11H,1-10H2,(H,16,17)

Standard InChI Key:  VTAFYINAQIGZCR-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5275210

    ---

Associated Targets(Human)

F13A1 Tchem Coagulation factor XIII (223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 238.33Molecular Weight (Monoisotopic): 238.1569AlogP: 3.06#Rotatable Bonds: 11
Polar Surface Area: 54.37Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.95CX Basic pKa: CX LogP: 4.03CX LogD: 1.62
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.60Np Likeness Score: 0.57

References

1. Al-Horani RA, Kar S..  (2020)  Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.,  200  [PMID:32502864] [10.1016/j.ejmech.2020.112442]

Source